You are here

Center for Translational Research and Molecular Biology of Cancer

prof. Piotr Widłak, PhD


telephone: +48 32 278 96 72

Beata Bęben
telephone: +48 32 278 97 52, fax: +48 32 278 98 40

The Center was founded in 2010 following the reorganization of the Institute of Oncology Research Division in Gliwice.

Scientific research conducted by the Center focuses on the molecular biology of cancer and the translation of research results into clinical practice (translational research, in short). General objectives of the Center cover novel methods of molecular diagnostics and experimental anticancer therapies.  Specifically, research focuses on:  (i) genetic risk factor in cancer predisposition, (ii) novel prognostic and predictive markers for cancer therapy; (iii) genomic and proteomic signatures for cancer identification and classification; (iv) novel diagnostic tools for monitoring the therapy; (v) pharmacology and biology of novel anticancer drugs; (vi) novel vectors and strategies of drug delivery.  Another group of basic research projects deals mostly with molecular responses to cellular stress, including: (i) DNA damage and repair; (ii) heat shock response, (iii) cellular senescence and apoptosis.  Besides basic research, investigators take part in implementing a series of diagnostic procedures based on the use of genetic and molecular cancer markers.  For more detailed information about research groups and their projects, please visit the Center web pages: